Clinical trial
Effectiveness and Cost-Effectiveness of NMR Metabolomics-Based Risk Assessment and Stratified Preventive Digital and Guideline-Directed Interventions in a Middle-Aged Population: A Population Cohort Study With an Embedded Pragmatic Randomised Trial and Health Economic Evaluation
NCT07820800 is registered in ClinicalTrials.gov with University of Eastern Finland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Cost-Effectiveness of NMR Metabolomics-Based Risk Assessment and Stratified Preventive Digital and Guideline-Directed Interventions in a Middle-Aged Population: A Population Cohort Study With an Embedded Pragmatic Randomised Trial and Health Economic Evaluation
- Lead sponsor
- University of Eastern Finland
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- March 31, 2028
- Enrollment
- 1,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cerebrovascular disease, chronic kidney disease, coronary heart disease, fatty liver disease, myocardial infarction, stroke, type 2 diabetes